PET/CT and MRI Model May Help Stratify Prostate Cancer Risk - Takeaways - MDSpire

PET/CT and MRI Model May Help Stratify Prostate Cancer Risk

Retrospective multicenter radiomics study showed moderate to high discrimination in two small external cohorts

  • By

  • Andrea Surnit

  • May 5, 2026

  • 4 min

Share

  • 1

    A machine learning radiomics model integrating PET/CT and MRI shows promise for prostate cancer risk stratification.

  • 2

    The study evaluated 488 patients, with significant findings from both internal and external validation cohorts.

  • 3

    Multimodal models outperformed single-modality approaches, achieving high AUC scores for clinically significant prostate cancer.

  • 4

    Limitations include retrospective design, small validation cohorts, and lack of prospective validation affecting generalizability.

  • 5

    The findings suggest further study of multimodal radiomics as a decision-support tool, not a replacement for biopsy.

Original Source(s)

PET/CT and MRI Model May Help Stratify Prostate Cancer Risk

  • by Andrea Surnit

  • May 5, 2026

Related Content

Most Salivary Gland Neoplasms Found to Be Benign in Single-Center Study

Analysis of 50 cases shows moderate diagnostic agreement between FNAC and histopathology and identifies pleomorphic adenoma as the most common neoplasm.

Renal Imaging Strategies Put to the Test

Noncontrast MRI technique evaluates renal tumor characterization in rapid acquisition.

Symposium on Magnetic Resonance in Radiation Therapy, 13th Annual

This internationally-recognized symposium is the premier global platform for showcasing the fast advancement of technology and the rapid integration of MRI into radiotherapy applications into the field of radiation oncology.

  • by

  • July 9, 2026

  • 1 min